×
0 0 0 0 0 0.0376428571428571 0.057142857142857 0.0642857142857142
Stockreport

Capricor Therapeutics and PPMD to Host Webinar for Duchenne Muscular Dystrophy Community on July 18

CAPRICOR THERAPEUTICS (CAPR)  More Company Research Source: GlobeNewswire
Last capricor therapeutics earnings: 8/9 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF LOS ANGELES, July 13, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) and Parent Project Muscular Dystrophy (PPMD) will host a webinar at 1 p.m. ET on July 18 to provide information about the HOPE-2 clinical trial, which is evaluating the safety and efficacy of repeat doses of CAP-1002 in boys and young men with Duchenne muscular dystrophy and reduced upper limb function. HOPE-2 is a Phase II, randomized, double-blind, placebo-controlled clinical trial that will randomize up to 84 participants at approximately 10-15 medical centers in the United States.   An earlier clinical trial, HOPE-Duchenne, found a single intracoronary dose of CAP-1002 in participants in advanced stages of Duchenne muscular dystrophy was generally safe and well tolerated. The trial also found significant and sustained improvement in cardiac and skeletal muscle function among those receiving CAP-1002 when compared to participants who received usual care only. “Please join PPMD and Capricor as we [Read more]

IMPACT SNAPSHOT EVENT TIME: CAPR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CAPR alerts
from News Quantified
Opt-in for
CAPR alerts

from News Quantified
Opt-in for
CAPR alerts

from News Quantified